Overview

Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.

Status:
Withdrawn
Trial end date:
2020-12-03
Target enrollment:
Participant gender:
Summary
2-week open-label safety, tolerability and pharmacokinetic study of methylphenidate HCl ERCT in 4-5 year old children with ADHD.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Methylphenidate